Лечение ЗППП
82. Walker CK, Kahn JG, Washington 4E, Peterson HB, Sweet RL Pelvic inflammatory disease meta-analysis of antimicrobial regimen efficacy J Infect Dis 1993,168 969-78
83. Matsuda S Clinical study of levofloxacin (LVFX) on the infectious diseases in the field of obstetrics and gynecology Chemotherapy 1992,40311-23
84. Martens MG, Gordon S, Yarborough DR Faro S Binder D Berkeley A Multicenter randomized trial of ofloxacin veisus cefoxitin and doxv-cycline in outpatient treatment of pelvic inflammatory disease South MedJ 1993,86 604-10
85. PeipertJF, Sweet RL, Kahn J, Reilly-Gauvin К Evaluation of ofloxacin in the treatment of laparoscopically documented acute pelvic inflammatory disease (salpingitis) Infect Dis Obstet Gynecol 1999,7 138-4
86. Walker CK, Workowski KA, Washington AE Soper D, Sweet RL Anaerobes in pelvic inflammatory disease implications for the Centers for Disease Control and Preventions guidelines for treatment of sexually transmitted diseases dm Infect Dis I999,28(Suppl 1) S29-S36
87. Witte EH, Peters AA, Smit IB van der Linden MC, Mouton RP, van der Meer JW, van Erp EJ A comparison of pefloxacin/metronidazole and doxycycline/metromdazole in the treatment of laparoscopically confirmed acute pelvic inflammatory disease Eur J Obstet Gynecol ReprodBiol 1993,50 153-8
88. Ridgway GL, Bevan C, Siddle N Azithromycm with or without metromdazole compared with cefoxitin, doxycycline and metromdazole in the treatment of laparoscopy confirmed acute pelvic inflammatory disease [Abstract] In Proceedings of the llth International Meeting of the International Society for STD Reseaich, New Orleans Fort Lee, New Jersey International Society for STD Research, 1995-
89. Cohen CR, Sinei S, Reilly M, et al Effect of human immunodeficiency virus type I infection upon acute salpingitis a laparoscopic study J Infect Dis 1998.178 1352-8
90. Bukesi EA, Cohen CR, Stevens CE et al Effects of human immunodeficiency virus 1 infection on microbial origins of pelvic inflammatory disease and on efficacy of ambulatory oral therapy Am J Obstet Gynecol 1999 18 1374-81
91. Irwin KL, Moorman AC, 0 Sullivan MJ et al Influence of human immunodeficiency virus infection on pelvic inflammatory disease Obstet Gynecol 2000.95 525-34
92. Kamb ML Cervical cancer screening of women attending sexually transmitted diseases clinics Clin Infect Dis I995,20(Suppl 1) S98-S103
93. American Cancer Society Guidelines for the cancer related checkup Atlanta, Georgia American Cancer Society, 1998
94. American College of Obstetricians and Gynecologists Routine cancer screening committee opinion 185 Washington, DC American College of Obstetricians and Gynecologists, 1997
95. National Cancer Institute Workshop The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses JAMA 1989 262 931-4
96. JayN, Moscich AB Human papillomavirus infections in women with HIV disease prevalence, risk, and management [Review] AIDS Reader 2000,10659-68
97. Kurman RJ Henson DE Herbst AL, Noller KL, Schiffman MH, National Cancer Institute Workshop Interim guidelines for management of abnormal cervical cytology JAMA 1994,271 1866-9
98. MacKellar DA Valleroy LA Secura GM, et al Two decades after vac- cine license hepatitis В immunization and infection among young men who have sex with men Am J Public Health 2001,91 965-71
99. CDC Immunization of adolescents recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics the American Academy of Family Physicians and the American Medical Association MMWR 1996 45 1-5
100. Mast ЕЕ, Williams IT, Alter MJ, Margolis HS Hepatitis В vaccination of adolescent and adult high-risk groups in the United States Vaccine 1998,16(Suppl) S27-S29
101. Alter MJ, Kruszon-Moran D, Hainan 0V, et al The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engi J Med 1999,341 556-62
102. CDC Recommendations for prevention and control of hepatitis C virus (HCV) infection and HC\'-related chronic disease MMWR 1998,47 (No RR-19) 1-39
103. Diegstag JL Sexual and perinatal transmission of hepatitis C Hepatology 1997 26(Suppl 1) S66-S70
104. Alter MJ Epidemiology of hepatitis C Hepatology 1999 26 (Suppi 1) S25-S65
105. Thomas DL, Zemlman JM Alter MJ, et al Sexual transmission of hepatitis C virus among patients attending Baltimore sexually transmitted disease clinics an analysis of 309 sex partnerships J Infect Dis 1995 171 768-75
106. HisadaM, O'Bnen TR, RosenbergPS, GoederlJJ Virus load and risk of heterosexual transmission of human immunodeficiency virus and hepatitis C virus by men with hemophilia the Multicenter Hemo-phiha Cohort Study J Infect Dis 2000 181 1475-8
107. BambergerJD, Waldo CR, Gerberding JL, Katz MH Postexposure prophylaxis foi human immunodeficiency virus (HIV) infection following sexual assault Am J Med 1999 106 323-6
108. CDC Public Health Service guidelines for the management of health care worker exposures to HIV and recommendations for post-exposure prophylaxis MMWR 1998,47'(No RR-7) 1-33
109. American Academy of Pediatrics Sexually transmitted disease in adolescents and children In Pickenng LK, ed 2000 Red book report of the Committee on Infectious Diseases 25dl ed Elk Grove Village, IL American Academy of Pediatrics, 2000 138-47
110. American Academy of Pediatrics Committee on Child Abuse and Neglect Guidelines for the evaluation of sexual abuse of children subject review Pediatrics 1999 103 186-91
111. Adams JA, Harper K, Krudson S A proposed system for the classifications of anogemtal findings in children with suspected child abuse Adolesc Pediatr Gynecol 1992 5 73-5
112. Shapiro RA, Schubert CJ, Siegel R Neissena gonorrhoeae infections in girls younger than 12 у ears of age evaluated for vagmitis Pediatrics 1999 104 (e72) l-ll
113. Lagerberg D Sexually transmitted diseases in children a serious con- sequence of sexual abuse and an indication of possible victimization of other children Acta Pediatrica 1998,87 1214-7
114. Dominguez KL Simonds RJ Postexposure prophylaxis In Zeichner SL, Read JS, eds Handbook of pediatnc HIV care Philadelphia Lippincott Williams & Wilkins, 1999 294-318.
СПИСОКСОКРАЩЕНИЙ
ACIP - The Immunisation Practices Advisory Committee
ACOG - American College of Obstetricians and Gynecologists
ACS - American Cancer Society
CDC - Centers for Disease Control and Prevention
DOT - directly observed therapy
FDA - Food and Drug Administration
FTA-ABS - Fluorescent treponemal antibody absorbed
MMWR - Morbidity and Mortality Weekly Report
N-9 - nonoxinol-9
RPR - Rapid plasma reagin
TP-PA - T. pallidum particle agglutination
VDRL - Venereal Disease Research Laboratory
AHK - амплификация нуклеиновых кислот
АПКНЗ - атипичные плоские клетки неопределенного значения
БВ - бактериальный вагиноз
